Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial

Routine 2-yr postradiotherapy biopsy is not recommended but can be considered in selected patients with unfavourable post-treatment prostate-specific antigen levels who are suitable for early salvage treatments.